Bernd J. Schmitz-Dräger

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.

E. Messing, H. Grossman, S. Hautmann, 2005, Urology.

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study

C. Stief, J. Schalken, B. Schmitz-Dräger, 2018, Prostate Cancer and Prostatic Diseases.

Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.

W. Schulz, B. Schmitz-Dräger, B. Jürgens, 1996, Cancer research.

The International Bladder Cancer Bank: proposal for a new study concept.

S. Groshen, N. Malats, M. Kogevinas, 2004, Urologic oncology.

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer.

A. Vlahou, H. Grossman, B. Schmitz-Dräger, 2014, Urologic oncology.